compounds having the formula , ## str1 ## wherein the groups r 1 , r 2 , r 3 , r 4 and r 5 are defined herein . the compounds of the present invention can be utilized to treat disease states capable of being modulated by inhibition of proteins which mediate cellular activity , such as tumor necrosis factor and / or phosphodiesterase iv .